X-70453771-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_021120.4(DLG3):c.1280G>A(p.Arg427His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000035 in 1,199,848 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000035 ( 0 hom. 16 hem. )
Consequence
DLG3
NM_021120.4 missense
NM_021120.4 missense
Scores
2
3
12
Clinical Significance
Conservation
PhyloP100: 9.47
Genes affected
DLG3 (HGNC:2902): (discs large MAGUK scaffold protein 3) This gene encodes a member of the membrane-associated guanylate kinase protein family. The encoded protein may play a role in clustering of NMDA receptors at excitatory synapses. It may also negatively regulate cell proliferation through interaction with the C-terminal region of the adenomatosis polyposis coli tumor suppressor protein. Mutations in this gene have been associated with X-linked cognitive disability. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.24771571).
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.0000349 (38/1088392) while in subpopulation EAS AF= 0.000998 (30/30069). AF 95% confidence interval is 0.000718. There are 0 homozygotes in gnomad4_exome. There are 16 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 16 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLG3 | NM_021120.4 | c.1280G>A | p.Arg427His | missense_variant | 8/19 | ENST00000374360.8 | NP_066943.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLG3 | ENST00000374360.8 | c.1280G>A | p.Arg427His | missense_variant | 8/19 | 1 | NM_021120.4 | ENSP00000363480.3 |
Frequencies
GnomAD3 genomes AF: 0.0000359 AC: 4AN: 111456Hom.: 0 Cov.: 22 AF XY: 0.0000297 AC XY: 1AN XY: 33640
GnomAD3 genomes
AF:
AC:
4
AN:
111456
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33640
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000242 AC: 4AN: 165533Hom.: 0 AF XY: 0.0000385 AC XY: 2AN XY: 51935
GnomAD3 exomes
AF:
AC:
4
AN:
165533
Hom.:
AF XY:
AC XY:
2
AN XY:
51935
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000349 AC: 38AN: 1088392Hom.: 0 Cov.: 31 AF XY: 0.0000451 AC XY: 16AN XY: 354698
GnomAD4 exome
AF:
AC:
38
AN:
1088392
Hom.:
Cov.:
31
AF XY:
AC XY:
16
AN XY:
354698
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000359 AC: 4AN: 111456Hom.: 0 Cov.: 22 AF XY: 0.0000297 AC XY: 1AN XY: 33640
GnomAD4 genome
AF:
AC:
4
AN:
111456
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33640
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Intellectual disability, X-linked 90 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 13, 2022 | - - |
Benign, no assertion criteria provided | case-control | Medical Genetic Institute of Henan Province, Henan Provincial People’s Hospital | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Benign
Sift
Benign
D;D;T
Sift4G
Benign
T;T;T
Polyphen
0.99
.;D;.
Vest4
MutPred
0.63
.;Loss of MoRF binding (P = 0.04);.;
MVP
MPC
2.0
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at